Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis

BACKGROUND: Tofacitinib is a disease-modifying antirheumatic drug (DMARD) which was recently approved by US Food and Drug Administration (FDA). There are several randomised clinical trials (RCTs) that have investigated the efficacy and safety of tofacitinib in adult patients with rheumatoid arthriti...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Ying, Wong, Angel YS, Chan, Esther W, Lau, Wallis CY, Man, Kenneth KC, Chui, Celine SL, Worsley, Alan J, Wong, Ian CK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819708/
https://www.ncbi.nlm.nih.gov/pubmed/24139404
http://dx.doi.org/10.1186/1471-2474-14-298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819708/
https://www.ncbi.nlm.nih.gov/pubmed/24139404
http://dx.doi.org/10.1186/1471-2474-14-298

Ejemplares similares